发明授权
- 专利标题： Peptide compound
- 专利标题（中）： 肽化合物
-
申请号： US14287514申请日： 2014-05-27
-
公开(公告)号： US09200051B2公开(公告)日： 2015-12-01
- 发明人: Taiji Asami , Ayumu Niida
- 申请人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理机构： Wenderoth, Lind & Ponack, L.L.P.
- 优先权： JP2013-111893 20130528
- 主分类号： C07K14/605
- IPC分类号： C07K14/605
摘要：
The present invention provides a novel peptide compound having an activating action on GLP-1 receptors and GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a partial sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. P1-Tyr-Aib-Glu-Gly-Thr-αMePhe-Thr-Ser-Asp-Tyr-A11-A12-A13-Leu-Asp-A16-A17-Ala-Gln-A20-Glu-Phe-Val-Lys-Trp-Leu-Leu-Lys-A29 SEQ ID NO: 1 (I)wherein each symbol is as defined herein.
公开/授权文献
- US20140357552A1 PEPTIDE COMPOUND 公开/授权日：2014-12-04
信息查询
